As Overdose Crisis Worsens, Cicilline Tells Trump Not to Kill Office of National Drug Control Policy - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
May 17, 2017 Newswires
Share
Share
Post
Email

As Overdose Crisis Worsens, Cicilline Tells Trump Not to Kill Office of National Drug Control Policy

Congressional Documents & Publications

WASHINGTON - Today, U.S. Congressman David N. Cicilline (D-RI), a member of the Bipartisan Task Force to Combat the Heroin Epidemic, released a letter he sent to President Donald Trump asking that he not move forward on a White House proposal to cut funding for the Office of National Drug Control Policy (ONDCP), the lead federal agency in the fight against opioid abuse and addiction. Under the White House's proposal, ONDCP would lose 95% of its current funding levels.

According to the Rhode Island Medical Examiner's Office, 336 people died last year as a result of a drug overdose, up from 290 in 2015. Nationwide, overdose deaths involving prescription and illicit opioids have quadrupled since 1999.

The full text of Cicilline's letter is embedded below. A PDF copy of the letter, as sent to the White House, can be downloaded by going to: http//cicilline.house.gov/sites/cicilline.house.gov/files/images/Letter_Opposing_Cuts_to_Drug_Policy_Office.pdf.

May 15, 2017

The Honorable Donald J. Trump

President of the United States

The White House

1600 Pennsylvania Avenue

Washington, D.C. 20500

Dear President Trump:

We write to strongly oppose your proposed cuts to the Office of National Drug Control Policy (ONDCP). On May 5, 2017, a draft budget document from the White House indicated that your administration proposed slashing the ONDCP budget by 95 percent and reducing funding for ONDCP from $388 million in 2017 to $24 million in 2018.

Our country is in the midst of a staggering drug overdose epidemic that is devastating families and communities across the country. In 2014, almost 2 million Americans abused or were dependent on prescription opioids and as many as 1,000 people are treated for misusing prescription opioids every day according to the Centers for Disease Control and Prevention,[1] making this one of the worst drug epidemics in recent history. Deaths involving prescription and illicit opioids--such as Vicodin, OxyContin, heroin and fentanyl--have been increasing at an alarming rate and have quadrupled since 1999.[2] In 2015 alone, nearly two-thirds, or approximately 33,000, drug overdose deaths involved opioids[3]--a death rate which surpassed for the first time deaths from automobile and firearms.[4] In order to reverse the tide on the drug addiction and deaths involving opioids, we must improve policy around and make necessary investments in prevention, recovery and treatment services.

The Office of National Drug Control Policy fills a critical need for an entity within the White House that can research and set rigorous, evidence-based policy and interventions for addressing the health issue of drug use and addiction; formulate a national strategy that identifies available resources across agencies within the federal government; and coordinate across federal agencies to carry out this national strategy. ONDCP has been the central agency to fulfill this role since 1982 and has valuable knowledge of the history and extent of our country's drug crisis.

Your proposed budget would nearly zero out ONDCP funding and cut roughly half the agency's staff. Gutting the ONDCP's budget, cutting staff, and losing the agency's historical knowledge would hobble the federal government's ability to maximize response to the drug overdose crisis--including focusing on the hardest hit communities; formulating responsive policy to treat drug use as a public health issue; addressing the urgent need to increase access to evidence-based treatment; and advising stakeholders on best practices for reducing substance abuse.

The proposed budget cut also includes eliminating two signature ONDCP grant programs with bipartisan support, the High Intensity Drug Trafficking Area (HIDTA) Program and the Drug-Free Communities (DFC) Support Program. HIDTA grants provide critical assistance to local law enforcement in creating tailored solutions to combat drug trafficking in their region while DFC grants have proven to be effective in reducing substance abuse among youth.

You rightfully made combating the opioid overdose epidemic a centerpiece of your 2016 campaign. To cut off funding to the main office tasked with this exact goal would not only be shortsighted, but would also undermine your pledge to the American people. We strongly urge you to reconsider proposed cuts to the Office of National Drug Control Policy and recommit necessary resources to battling the drug addiction and overdose crisis.

Sincerely,

David N. Cicilline

Member of Congress

cc:

Michael Mulvaney

Director

The Office of Management and Budget

725 17th Street, NW

Washington, DC 20503

Read this original document at: http://cicilline.house.gov/press-release/overdose-crisis-worsens-cicilline-tells-trump-not-kill-office-national-drug-control

Older

Wyden Statement at Finance Committee Hearing on Chronic Care

Newer

Congressman Sensenbrenner Introduces the Disability Integration Act in the House of Representatives

Advisor News

  • House panel advances CLEAR Forms Act backed by IRI
  • Modifying life insurance based on evolving needs
  • Gen X faces ‘pension envy’ as they head into retirement
  • Your client wants to cash out an annuity. Here’s what to consider
  • How student loan debt impacts 401(k) balances
More Advisor News

Annuity News

  • A-Cap strikes back with lawsuit accusing SC regulators of sloppy process, leaking secrets
  • AM Best to Discuss Its Views on Private Credit Surge and Risks at 2026 NAIC/NIPR Insurance Summit
  • OID recovers $260M in life insurance benefits
  • NUNN BILLS TO COMBAT PAYMENT SCAMS, CUT FINANCIAL RED TAPE PASS FINANCIAL SERVICES COMMITTEE
  • SS&C Black Diamond Expands Annuities & Insurance Marketplace with New Insurance Capabilities and Carriers
More Annuity News

Health/Employee Benefits News

  • SHIIP counseling available this fall at KRHC
  • Researchers from University of Chicago Discuss Findings in Artificial Intelligence (Molecules To Market: a Probabilistic Artificial Intelligence Framework for Predicting Managed Care Adoption At the Level of Drug Discovery): Artificial Intelligence
  • Idaho looks at Montana model amid rising health insurance costs
  • HHS' OFFICE FOR CIVIL RIGHTS SETTLES HIPAA INVESTIGATION OF AMBRY GENETICS PHISHING ATTACK AFFECTING 225,000 INDIVIDUALS
  • FACT-CHECK: BRAND DRUGMAKERS' RELENTLESS PRICE HIKES CAUSE HIGHER PREMIUMS
Sponsor
More Health/Employee Benefits News

Life Insurance News

  • Judge OKs class action against State Farm over PHL life insurance policies
  • AM Best Assigns Credit Ratings to Lasso Healthcare Insurance Company
  • A-Cap insurers face new takeover push in South Carolina
  • AM Best Affirms Credit Ratings and Assigns National Scale Rating to Allianz Ayudhya General Insurance Public Company Limited
  • Winged Keel Group Welcomes Scott Henderson, Expanding Institutional Relationships and Presence Across Midwest
Sponsor
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Lauren Sinnott Named to Ragan’s Top Women in Marketing Awards, Class of 2026 
  • Classic Car Insurer OpenRoad Insurance Expands to 40 U.S. States in Two Years
  • How Aspire General Turned an Early Technology Bet Into Claims Automation at Scale with Kyber
  • Adjusto launches AI-Native contents claims services powered by its technology platform
  • URL Insurance Group Celebrates 40 Years of Service, Growth, and Industry Leadership
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.